Natriuretic peptides - physiology, pathophysiology and clinical use in heart failure

Physiological Research

Volumn 58, Issue 2, 2009, Pages 171-177

  Krupicka J ^a   Janota, T ^a   Kasalova Z ^a   Hradec, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

BNP; Heart failure diagnosis; Heart failure treatment; Natriuretic peptides; NT proBNP; OPTIMA study

Indexed keywords

NATRIURETIC FACTOR;

HEART FAILURE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

HEART FAILURE; HUMANS; NATRIURETIC PEPTIDES;

EID: 66349123566     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (38)

1. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107: 1278-1283, 2003.
2. Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL, Jr.: Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 47: 91-97, 2006.
3. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A: N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110: 2168-2174, 2004.
4. Carstens J, Gronbaek H, Larsen HK, Pedersen EB, Vilstrup H: Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention. BMC Gastroenterol 7: 1, 2007.
5. Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R: Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 6: 365-368, 2004.
6. Corell P, Gustafsson F, Kistorp C, Madsen LH, Schou M, Hildebrandt P: Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure. Int J Cardiol 117: 395-402, 2007.
7. Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM,Burnett JC, Jr: Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 47: 345-353, 2006.
8. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28: 89-94, 1981.
9. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P: Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 11: S15-20, 2005.
10. Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Trawinski J, Amann-Zalan I, Hoersch S, Katus HA: NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy. Eur J Heart Fail 6: 343-350, 2004.
11. Ho KK, Pinsky JL, Kannel WB, Levy D: The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22: 6A-13A, 1993.
12. Hogenhuis J, Voors AA, Jaarsma T, Hillege HL, Boomsma F, Van Veldhuisen DJ: Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail 7: 81-86, 2005.
13. Jakubík P, Janota T, Widimský J, Jr, Zelinka T, Štrauch B, Petrák O, Benáková H, Bezdíčková D, Wichterle D, Zima T, Hradec J: Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration. Blood Press 15: 302-307, 2006.
14. Januzzi JL, Van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalobel M, Pinto YM, Richards M: NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The International Collaborative of NT-proBNP Study. Eur Heart J 27: 330-337, 2006.
15. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juilliere Y: Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49: 1733-1739, 2007.
16. Kawai K, Hata K, Tanaka K, Kubota Y, Inoue R, Masuda E, Miyazaki T, Yokoyama M: Attenuation of biologic compensatory action of cardiac natriuretic peptide system with aging. Am J Cardiol 93: 719-723, 2004.
17. Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, Maisel A: A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7: 21-29, 2001.
18. Kone BC: Molecular biology of natriuretic peptides and nitric oxide synthases. Cardiovasc Res 51: 429-441, 2001.
19. Krupička J, Janota T, Hradec J: Is it possible to treat heart failure by plasma BNP levels? (abstr.) Cor Vasa 49: 54, 2007 (in Czech).
20. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 339: 321-328, 1998.
21. Lubien E, Demaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS: Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105: 595-601, 2002.
22. Maack T: The broad homeostatic role of natriuretic peptides. Arq Bras Endocrinol Metabol 50: 198-207, 2006.
23. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AHB, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA,, The Breathing not Properly Multinational Study I: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161-167, 2002.
24. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS: B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106: 416-422, 2002.
25. McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS: B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41: 571-579, 2003.
26. Murdoch DR, McDonagh TA, Byrne J, Blue L, Farmer R, Morton JJ, Dargie HJ: Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 138: 1126-1132, 1999.
27. Nakao K, Ogawa Y, Suga S, Imura H: Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors. J Hypertens 10: 1111-1114, 1992.
28. Ogawa A, Seino Y, Yamashita T, Ogata K, Takano T: Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Circ J 70: 1372-1378, 2006.
29. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC, Jr.: Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40: 976-982, 2002.
30. Richards AM, Crozier IG, Yandle TG, Espiner EA, Ikram H, Nicholls MG: Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 69: 414-417, 1993.
31. Richards AM, Doughty R, Nicholls MG, Macmahon S, Ikram H, Sharpe N, Espiner EA, Frampton C, Yandle TG: Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. Circulation 99: 786-792, 1999.
32. Sanderson JE, Chan WW, Hung YT, Chan SK, Shum IO, Raymond K, Woo KS: Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker. Br Heart J 74: 502-507, 1995.
33. Silver MA, Maisel A, Yancy CW, McCullough PA, Burnett JC, JR., Francis GS, Mehra MR, Peacock WFT, Fonarow G, Gibler WB, Morrow DA, Hollander J: BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 10: 1-30, 2004.
34. Sudoh T, Minamino N, Kangawa K, Matsuo H: C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168: 863-870, 1990.
35. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM: Treatment OF Heart Failure Guided BY Plasma Aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355: 1126-1130, 2000.
36. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Matsui T, Kinoshita M: Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 37: 1228-1233, 2001.
37. Vanderheyden M, Bartunek J, Goethals M: Brain and other natriuretic peptides: molecular aspects. Eur J Heart Fail 6: 261-268, 2004.
38. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS: Impact of obesity on plasma natriuretic peptide levels. Circulation 109: 594-600, 2004.